Compare ANET & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANET | SYK |
|---|---|---|
| Founded | 2004 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2B | 141.2B |
| IPO Year | 2014 | N/A |
| Metric | ANET | SYK |
|---|---|---|
| Price | $123.71 | $369.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 16 |
| Target Price | $163.93 | ★ $434.19 |
| AVG Volume (30 Days) | ★ 6.4M | 1.7M |
| Earning Date | 02-17-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | ★ 26.15 | N/A |
| EPS | 2.63 | ★ 7.61 |
| Revenue | $8,448,346,000.00 | ★ $24,381,000,000.00 |
| Revenue This Year | $29.46 | $11.98 |
| Revenue Next Year | $21.86 | $8.60 |
| P/E Ratio | ★ $46.73 | $48.29 |
| Revenue Growth | ★ 27.75 | 10.95 |
| 52 Week Low | $59.43 | $329.16 |
| 52 Week High | $164.94 | $406.19 |
| Indicator | ANET | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 39.49 | 62.97 |
| Support Level | $130.88 | $344.63 |
| Resistance Level | $141.41 | $370.88 |
| Average True Range (ATR) | 3.86 | 5.35 |
| MACD | -0.57 | 2.33 |
| Stochastic Oscillator | 4.51 | 93.60 |
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.